DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2020年5月18日 (月) 午前 10:00 - 2020年5月20日 (水) 午後 3:15

(US Eastern Standard Time)

Fort Washington, PA 19034

Advertising and Promotion Regulatory Affairs Conference

Session 5: Engaging with Patients to Diversify Advertising and Promotional Activities

Session Chair(s)

Joanne  Hawana, JD, MS

Joanne Hawana, JD, MS

Member

Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States

Medical product developers are interacting with patients and caregivers more than ever before in unique and diverse ways, from recruiting clinical trial subjects through social media outlets to providing educational information about complex therapies or diseases. This area of focus has accelerated in recent years as FDA and other regulators encourage “patient-focused” drug and medical device product development. Patients are also more likely to be involved in their healthcare plans today than ever before, and they seek out medical knowledge from a variety of sources, including pharmaceutical and medical device companies developing products for their specific disease or condition but also patient organizations, government sources, and elsewhere. Although there are numerous opportunities for companies to engage directly with patients and caregivers, there also are legal and regulatory risks and barriers to certain activities and limitations on what companies can communicate to consumers as part of these activities. This session will explore the opportunities and challenges associated with companies’ outreach to patients and caregivers. We will also discuss ways to ensure such activities do not run afoul of regulatory requirements and provide tips to ensure promotional efforts that incorporate patient-derived information remain in compliance with applicable laws.

Learning Objective :
  • Articulate opportunities and compliance risks associated with different forms of patient engagement
  • Discuss mechanisms for ensuring patient-facing materials that are not clearly promotional in nature (e.g., clinical trial recruitment notices, educational content) do not violate applicable laws and regulations
  • Identify potential regulatory violations when presented with case studies of promotional materials involving patient-derived information

Speaker(s)

Pamela  Goldberg, MBA

Panelist

Pamela Goldberg, MBA

Medical Device Innovation Consortium, United States

President and CEO

Minerva  Hughes, JD, PhD

Panelist

Minerva Hughes, JD, PhD

CDRH, FDA, United States

Regulatory Counsel, Office of Clinical Evidence and Analysis

Lisa J  Pieretti, MBA

Panelist

Lisa J Pieretti, MBA

International Hyperhidrosis Society, United States

Executive Director; Co-Founder

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。